These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1946783)

  • 21. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.
    Kolasinska-Malkowska K; Filipiak KJ; Gwizdala A; Tykarski A
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):759-71. PubMed ID: 18510491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC; Perazella MA
    Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
    van den Born BJ; Koopmans RP; van Montfrans GA
    Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sounds in medicine. On the historical basis of modern diagnosis].
    Lachmund J
    Wien Klin Wochenschr; 2009; 121(15-16):491-500. PubMed ID: 19787318
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart.
    Lim HS; MacFadyen RJ; Lip GY
    Arch Intern Med; 2004 Sep; 164(16):1737-48. PubMed ID: 15364666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The renin-angiotensin-aldosterone system, angiotensin I converting enzyme, and the ACE-inhibitors. Historical perspective and recent findings].
    Gensini GF; Lippi D; Conti AA
    Recenti Prog Med; 2002 Oct; 93(10):544-53. PubMed ID: 12405014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
    Ecder T; Schrier RW
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):369-74. PubMed ID: 15151483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evolution of treatment options for hypertension].
    Fursov AN; Potekhin NP; Orlov FA; Zakharova EG
    Voen Med Zh; 2013 Jul; 334(7):26-31. PubMed ID: 24341007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal function, sodium excretion and the renin-angiotensin-aldosterone system in relation to blood pressure. An epidemiological and physiological study.
    Ljungman S
    Acta Med Scand Suppl; 1982; 663():108. PubMed ID: 6983814
    [No Abstract]   [Full Text] [Related]  

  • 31. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA
    J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trials in nephrology: success or failure.
    Garcia-Donaire JA; Segura J; Ruilope LM
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):59-63. PubMed ID: 17293678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
    Ratto E; Leoncini G; Viazzi F; Pontremoli R
    G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Is hypertension a disease of the intra-renal renin-angiotensin system?].
    Ménard J
    Bull Acad Natl Med; 2004; 188(4):661-4; discussion 664-5. PubMed ID: 15587685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reflections on hypertension in relations to 100 years of Riva-Rocci].
    Birkenhäger WH; de Leeuw PW
    Ned Tijdschr Geneeskd; 1996 Dec; 140(52):2600-3. PubMed ID: 9026735
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theodore Caldwell Janeway, clinician and pathophysiologist.
    Prutkin JM
    Clin Cardiol; 2007 Mar; 30(3):146-8. PubMed ID: 17385707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.